Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
Tu1269:异源与同源腺病毒载体和mRNA SARS-CoV-2疫苗在肝移植受者中的免疫原性和安全性
期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines11101538
Narongkiatikhun, Phoom; Noppakun, Kajohnsak; Chaiwarith, Romanee; Winichakoon, Poramed; Vongsanim, Surachet; Suteeka, Yuttitham; Pongsuwan, Karn; Kusirisin, Prit; Wongsarikan, Nuttanun; Fanhchaksai, Kanda; Khamwan, Chantana; Dankai, Dararat; Ophascharoensuk, Vuddhidej; Sriphoosanaphan, Supachaya; Suksawatamnuay, Sirinporn; Srisoonthorn, Nunthiya; Siripon, Nipaporn; Thaimai, Panarat; Makhasen, Wanwisar; Mungnamtrakul, Nawakodchamon; Thanapirom, Kessarin; Nonthasoot, Bunthoon; Hansasuta, Pokrath; Komolmit, Piyawat